methylprednisolone hemisuccinate has been researched along with mexiletine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Akbiyik, F; Caner, HH; Kaptanoglu, E; Sürücü, HS | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and mexiletine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury.
Topics: Analysis of Variance; Animals; Antioxidants; Lipid Peroxidation; Male; Methylprednisolone Hemisuccinate; Mexiletine; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries | 1999 |